Inhibited proliferation of human lung fibroblasts by LPS is through IL-6 and IL-8 release

Cytokine

Volumn 54, Issue 3, 2011, Pages 289-295

  Zhang, Jing ^a   Wu, Lian ^b   Qu, Jie Ming ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Human lung fibroblast; Interleukin 6; Interleukin 8; Lipopolysaccharide; Proliferation

Indexed keywords

HISTONE DEACETYLASE 2; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; LUNG FIBROBLAST; LUNG PARENCHYMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SUPERNATANT;

CELL PROLIFERATION; FIBROBLASTS; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE 2; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 79955136308     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.02.018     Document Type: Article

References (49)

1. Global Initiative for Chronic Obstructive Lung Disease. Workshop report: global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease [internet] (updated 2009). Available from: http://www.goldcopd.com.
2. Hogg J.C., Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 2009, 4:435-459.
3. Sharafkhaneh A., Hanania N.A., Kim V. Pathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc 2008, 5:475-477.
4. Chung K.F., Adcock I.M. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008, 31:1334-1356.
5. Hostettler K.E., Roth M., Burgess J.K., et al. Airway epithelium-derived transforming growth factor-beta is a regulator of fibroblast proliferation in both fibrotic and normal subjects. Clin Exp Allergy 2008, 38:1309-1317.
6. Muller K.C., Welker L., Paasch K., et al. Lung fibroblasts from patients with emphysema show markers of senescence in vitro. Respir Res 2006, 7:32-41.
7. Holz O., Zühlke I., Jaksztat E., et al. Lung fibroblasts from patients with emphysema show a reduced proliferation rate in culture. Eur Respir J 2004, 24:575-579.
8. Togo S., Holz O., Liu X., et al. Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med 2008, 178:248-260.
9. Michel O. Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditions. J Endotoxin Res 2003, 9:293-300.
10. Sarir H., Henricks P.A., van Houwelingen A.H., et al. Cells, mediators and Toll-like receptors in COPD. Eur J Pharmacol 2008, 585:346-353.
11. George C.L., Jin H., Wohlford-Lenane C.L., et al. Endotoxin responsiveness and subchronic grain dust-induced airway disease. Am J Physiol Lung Cell Mol Physiol 2001, 280:L203-L213.
12. Vogelzang P.F., van der Gulden J.W., Folgering H., et al. Endotoxin exposure as a major determinant of lung function decline in pig farmers. Am J Respir Crit Care Med 1998, 157:15-18.
13. Vernooy J.H.J., Dentener M.A., van Suylen R.J., et al. Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology. Am J Respir Cell Mol Biol 2002, 26:152-159.
14. He Z., Zhu Y., Jiang H. Toll-like receptor 4 mediates lipopolysaccharide-induced collagen secretion by phosphoinositide3-kinase-akt pathway in fibroblasts during acute lung injury. J Receptors Signal Transduction 2009, 29:119-125.
15. Al-Nasiry S., Geusens N., Hanssens M., et al. The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod 2007, 22:1304-1309.
16. Medzhitov R., Janeway C. Innate immunity. N Engl J Med 2000, 343:338-344.
17. West M.A., Bennet T., Seatter S.C., et al. LPS pretreatment reprograms macrophage LPS-stimulated TNF and IL-1 release without protein tyrosine kinase activation. J Leukoc Biol 1997, 61:88-95.
18. Xia Z., Wang G., Ge S., et al. Alpha 1-antitrypsin and alpha 1-acid glycoprotein reduce the sensitivity of human dermal fibroblast to endotoxin. Chin J Traumatol 2001, 4:199-203.
19. Hill S.J., Ebersole J.L. The effect of lipopolysaccharide on growth factor-induced mitogenesis in human gingival fibroblasts. J Periodontol 1996, 67:1274-1280.
20. Bartold P.M., Narayanan A.S., Page R.C. Platelet-derived growth factor reduces the inhibitory effects of lipopolysaccharide on gingival fibroblast proliferation. J Periodontal Res 1992, 27:499-505.
21. Larsson L., Szponar B., Pehrson C. Tobacco smoking increases dramatically air concentrations of endotoxin. Indoor Air 2004, 14:421-424.
22. Keatings V.M., Collins P.D., Scott D.M., et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996, 153:530-534.
23. Ko F.W., Leung T.F., Wong G.W., et al. Measurement of tumor necrosis factor-alpha, leukotriene B4, and interleukin 8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2009, 4:79-86.
24. Schulz C., Wolf K., Harth M., et al. Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers, and never-smokers. Respiration 2003, 70:254-261.
25. Cordoba-Lanus E., de-Torres J.P., Lopez-Aguilar C., et al. Association of IL-6 gene polymorphisms and COPD in a Spanish population. Respir Med 2008, 102:1805-1811.
26. Eddahibi S., Chaouat A., Tu L., et al. Interleukin-6 gene polymorphism confers susceptibility to pulmonary hypertension in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006, 3:475-476.
27. Lee T.M., Lin M.S., Chang N.C. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol 2008, 101:530-535.
28. Barnes P.J. Alveolar macrophages in chronic obstructive pulmonary disease (COPD). Cell Mol Biol (Noisy-le-grand) 2004, 50:OL627-OL637.
29. Vecchio D., Arezzini B., Pecorelli A., et al. Reactivity of mouse alveolar macrophages to cigarette smoke is strain dependent. Am J Physiol Lung Cell Mol Physiol 2010, 298:L704-L713.
30. Xu X., Wang H., Wang Z., et al. Plasminogen activator inhibitor-1 promotes inflammatory process induced by cigarette smoke extraction or lipopolysaccharides in alveolar epithelial cells. Exp Lung Res 2009, 35:795-805.
31. Mukhopadhyay S., Hoidal J.R., Mukherjee T.K. Role of TNFalpha in pulmonary pathophysiology. Respir Res 2006, 7:125-133.
32. Ito K., Yamamura S., Essilfie-Quaye S., et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-{kappa}B suppression. J Exp Med 2006, 203:7-13.
33. Ito K., Barnes P.J., Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 2000, 20:6891-6903.
34. Adcock I.M., Tsaprouni L., Bhavsar P., et al. Epigenetic regulation of airway inflammation. Curr Opin Immunol 2007, 19:694-700.
35. Barnes P.J. Histone deacetylase-2 and airway disease. Ther Adv Respir Dis 2009, 3:235-243.
36. Ito K., Ito M., Elliott W.M., et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005, 352:1967-1976.
37. Barnes P.J. Role of HDAC2 in the pathophysiology of COPD. Annu Rev Physiol 2009, 71:451-464.
38. Rajendrasozhan S., Yang S.R., Edirisinghe I., et al. Deacetylases and NF-κB in redox regulation of cigarette smoke-induced lung inflammation: epigenetics in pathogenesis of COPD. Antioxid Redox Signal 2008, 10:799-812.
39. Musikacharoen T., Yoshikai Y., Matsuguchi T. Histone acetylation and activation of camp-response element-binding protein regulate transcriptional activation of MKP-M in lipopolysaccharide-stimulated macrophages. J Biol Chem 2003, 278:9167-9175.
40. Chen J., Luo J., Li B., et al. E1A has no effect on LPS-induced IL-6 secretion in rat alveolar epithelial cells. Respiration 2009, 78:84-92.
41. Tsaprouni L.G., Ito K., Adcock I.M., et al. Suppression of lipopolysaccharide- and tumour necrosis factor-alpha-induced interleukin (IL)-8 expression by glucocorticoids involves changes in IL-8 promoter acetylation. Clin Exp Immunol 2007, 150:151-157.
42. Szulakowski P., Crowther A.J., Jimenez L.A., et al. The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 174:41-50.
43. Rahman I., Marwick J., Kirkham P. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol 2004, 68:1255-1267.
44. Bowler R.P., Barnes P.J., Crapo J.D. The role of oxidative stress in chronic obstructive pulmonary disease. COPD 2004, 1:255-277.
45. Montuschi P., Collins J.V., Ciabattoni G., et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000, 162:1175-1177.
46. Paredi P., Kharitonov S.A., Leak D., et al. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 162:369-373.
47. Pera T., Gosens R., Lesterhuis A.H., et al. Cigarette smoke and lipopolysaccharide induce a proliferative airway smooth muscle phenotype. Respir Res 2010, 11:48-59.
48. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001, 2:675-680.
49. Biswas S.K., Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009, 30:475-487.